dromlakhani/md2skill/ata-prolactinoma-axis-reassess
Claude Code and agent skill by dromlakhani/md2skill
- community
Checking that the SKILL.md file is still in the repository.
Recommends reassessing all pituitary axes in patients with macroprolactinoma and central hypogonadism who have had successful dopamine agonist treatment. Use when managing a macroprolactinoma patient after dopamine agonist treatment with normalized prolactin and tumor shrinkage.
Install
npx vskill@latest install dromlakhani/md2skill/ata-prolactinoma-axis-reassessSKILL.md
The same SKILL.md was published earlier as dromlakhani/md2skill/ata-prolactinoma-axis-reassess.
Reassess pituitary axes after dopamine agonist treatment in macroprolactinoma
STEP 1 — Gather Information
Confirm macroprolactinoma diagnosis (MRI >10mm), central hypogonadism (low testosterone/E2 with inappropriately low LH/FSH), and successful dopamine agonist treatment (normoprolactinemia, tumor shrinkage ≥30%, symptom improvement). Collect baseline pituitary hormones (cortisol, fT4, TSH, IGF-1, gonadotropins, sex steroids) and current symptoms.
STEP 2 — Rule In / Rule Out
Is there evidence of successful dopamine agonist treatment? If yes, proceed to axis reassessment; if no, optimize dopamine agonist dose or consider surgery/radiation before reassessment.
STEP 3 — Classify or Stratify
Assess each pituitary axis: adrenal (AM cortisol or ACTH stim), thyroid (fT4/TSH), gonadal (testosterone/E2, LH/FSH), GH (IGF-1), and DI (serum/urine osmolarity if polyuria). Classify each as sufficient, borderline, or deficient based on age-adjusted reference ranges.
STEP 4 — Decide
For any deficient axis, initiate appropriate hormone replacement per endocrine guidelines; for borderline, repeat testing in 3-6 months; for sufficient, continue surveillance with annual clinical review and pituitary MRI.
Clinical Guardrails / Mimics / Pitfalls
Do not assume normalization of prolactin implies recovery of other axes; do not discontinue dopamine agonist without confirming tumor stability; avoid empiric hormone replacement without biochemical confirmation; consider macroprolactinoma regrowth if symptoms worsen despite biochemical control.
Concrete Clinical Example
A 42-year-old man with macroprolactinoma (12mm) and central hypogonadism (testosterone 150 ng/dL, LH 1.2 IU/L) achieved normoprolactinemia (<20 ng/mL) and 50% tumor shrinkage after 6 months of cabergoline. Reassessment revealed low IGF-1 (80 ng/mL) and low testosterone (120 ng/dL); he started testosterone gel and GH replacement.
Source: Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2016-2118
Security
- Security scanPassed, 100 of 100Pattern checks on the skill's files.
- Model reviewPassed
Quality evaluation
- Task evaluationNot runNo evaluation yet. Run one in Skill Studio.
Source
- SKILL.md in the repositoryCheckingskills/endocrinology/pituitary/ata-prolactinoma-axis-reassess/SKILL.md
Popularity
- Repository stars
- 12
- Repository forks
- 1
- 7-day trend score
- 18
Stars and forks are for the whole GitHub repository, not this skill alone. Not refreshed yet.
Works with
Any agent vskill installs to: 56 targets in all. These 39 have a page on this site.
- Claude Code
- Cursor
- GitHub Copilot
- Windsurf
- Codex
- Gemini CLI
- Cline
- Amp
- Roo Code
- Goose
- Continue
- Kilo Code
- Junie
- Trae
- OpenHands
- Qwen Code
- AI Agent
- Tabnine Chat
- Sourcegraph Cody
- Amazon Q
- Firebase Genkit
- Sweep
- Devin
- Phind
- Mentat
- Claude Desktop
- Aider
- GPT Pilot
- Plandex
- bolt.new
- v0
- Replit Agent
- Anse
- TypingMind
- BetterChatGPT
- LibreChat
- Warp AI
- Pieces
- Fig AI
Embed badge
[](https://verified-skill.com/skills/dromlakhani/md2skill/ata-prolactinoma-axis-reassess)